[{"id":"a115c1d3-c5fc-434a-b235-92cb082eace4","acronym":"","url":"https://clinicaltrials.gov/study/NCT02844699","created_at":"2021-01-18T13:57:46.284Z","updated_at":"2024-07-02T16:37:17.666Z","phase":"Phase 1/2","brief_title":"A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer","source_id_and_acronym":"NCT02844699","lead_sponsor":"Panacela Labs LLC","biomarkers":" CD4 • TLR5","pipe":"","alterations":" ","tags":["CD4 • TLR5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Mobilan (M-VM3)"],"overall_status":"Unknown status","enrollment":" Enrollment 24","initiation":"Initiation: 07/01/2016","start_date":" 07/01/2016","primary_txt":" Primary completion: 01/01/2018","primary_completion_date":" 01/01/2018","study_txt":" Completion: 01/01/2018","study_completion_date":" 01/01/2018","last_update_posted":"2017-09-20"}]